EditorialEditorial
Anti-Tumor Necrosis Factor Agents Are Mostly Used in Patients with Established Rheumatoid Arthritis Compared to Early Disease — A Reflection of Adequate Clinical Practice
BOULOS HARAOUI
The Journal of Rheumatology August 2009, 36 (8) 1561-1562; DOI: https://doi.org/10.3899/jrheum.090594
BOULOS HARAOUI
REFERENCES
- 1.↵
- 2.
- 3.↵
- Breedveld FC,
- Weisman MH,
- Kavanaugh AF,
- et al.
- 4.↵
- 5.↵
- 6.↵
- Lee SJ,
- Chang H,
- Yazici Y,
- Greenberg JD,
- Kremer JL,
- Kavanaugh A
- 7.↵
- 8.
- 9.↵
- Verstappen SMM,
- Jacobs JWG,
- van der Veen MJ,
- et al.
- 10.↵
- van der Kooij SM,
- de Vries-Bouwstra JK,
- Goekoop-Ruiterman YPM,
- et al.
- 11.↵
- 12.
- 13.↵
- Hetland ML,
- Lindegaard HM,
- Hansen A,
- et al.
- 14.↵
- Soderlin MK,
- Geborek P
In this issue
The Journal of Rheumatology
Vol. 36, Issue 8
1 Aug 2009
Anti-Tumor Necrosis Factor Agents Are Mostly Used in Patients with Established Rheumatoid Arthritis Compared to Early Disease — A Reflection of Adequate Clinical Practice
BOULOS HARAOUI
The Journal of Rheumatology Aug 2009, 36 (8) 1561-1562; DOI: 10.3899/jrheum.090594